Indication-wide drug pricing: Insights from the pharma market.

ABSTRACT:

Background

Pharmaceutical spending has been increasing rapidly for years and is higher than ever before. To control the rising costs, countries are implementing regulatory frameworks such as (internal) reference pricing, price cuts or generics substitution. Internal reference pricing establishes a reference price within a country which serves as the maximum level of reimbursement for a group of pharmaceuticals. Price setting in the German market is especially relevant for many European countries, which use Germany as a reference country for their own price setting.

Methods

We evaluate pharmaceutical price dynamics for not reference priced pharmaceuticals (NRPs) as well as for reference priced pharmaceuticals (RPs) in Germany-referring to the internal reference price system.

SUBMITTER: Siegmeier F 

PROVIDER: S-EPMC9422096 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature